ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
61.360,18
0,91%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Taiwan Liposome Company Ltd (TLC)

  7. Taiwan Liposome Company Ltd (TLC) Notícias

TLC

Taiwan Liposome (TLC)

Taiwan Liposome Company Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TLC
DataHoraFonteTítuloCódigoCompanhia
20/11/202305:54GlobeNewswire Inc.Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts SessionNASDAQ:TLCTaiwan Liposome Company Ltd
08/11/202306:54GlobeNewswire Inc.TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACRNASDAQ:TLCTaiwan Liposome Company Ltd
13/06/202207:30GlobeNewswire Inc.TLC Announces TLC599 Agreement with EndoNASDAQ:TLCTaiwan Liposome Company Ltd
07/03/202206:57GlobeNewswire Inc.TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & TherapyNASDAQ:TLCTaiwan Liposome Company Ltd
18/02/202218:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
27/01/202208:13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TLCTaiwan Liposome Company Ltd
15/10/202107:33Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
15/09/202112:57Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:TLCTaiwan Liposome Company Ltd
08/09/202105:40GlobeNewswire Inc.TLC Announces Voluntary Delisting and Deregistration of American Depositary SharesNASDAQ:TLCTaiwan Liposome Company Ltd
26/08/202117:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
12/08/202106:44GlobeNewswire Inc.TLC Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
05/08/202115:38Edgar (US Regulatory)Tender Offer/rights Offering Notification (cb)NASDAQ:TLCTaiwan Liposome Company Ltd
05/07/202107:16GlobeNewswire Inc.TLC Announces Details of Stock Swap TransactionsNASDAQ:TLCTaiwan Liposome Company Ltd
26/05/202105:30GlobeNewswire Inc.TLC and Zydus Enter Agreement to Launch AmphoTLC™ in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
25/05/202106:05GlobeNewswire Inc.TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
23/05/202110:00GlobeNewswire Inc.InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...NASDAQ:TLCTaiwan Liposome Company Ltd
14/05/202108:32GlobeNewswire Inc.TLC Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
03/05/202106:15GlobeNewswire Inc.TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years RunningNASDAQ:TLCTaiwan Liposome Company Ltd
26/04/202106:30GlobeNewswire Inc.InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) CongressNASDAQ:TLCTaiwan Liposome Company Ltd
02/03/202106:00GlobeNewswire Inc.TLC to Present at Upcoming Virtual Investor ConferencesNASDAQ:TLCTaiwan Liposome Company Ltd
16/02/202114:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TLCTaiwan Liposome Company Ltd
12/02/202118:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TLCTaiwan Liposome Company Ltd
05/02/202106:15GlobeNewswire Inc.TLC Reports Fiscal Year End 2020 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
04/01/202107:00GlobeNewswire Inc.TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.NASDAQ:TLCTaiwan Liposome Company Ltd
28/12/202006:00GlobeNewswire Inc.TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainNASDAQ:TLCTaiwan Liposome Company Ltd
18/12/202006:00GlobeNewswire Inc.TLC Provides Corporate Update at Investor ConferenceNASDAQ:TLCTaiwan Liposome Company Ltd
03/11/202009:37GlobeNewswire Inc.TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science JournalNASDAQ:TLCTaiwan Liposome Company Ltd
28/10/202005:50GlobeNewswire Inc.TLC Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
21/10/202005:45GlobeNewswire Inc.TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business OfficerNASDAQ:TLCTaiwan Liposome Company Ltd
14/10/202005:40GlobeNewswire Inc.TLC Enrolls First Subject in Phase I Clinical Trial of Inhalable Anti-COVID-19 Program (TLC19)NASDAQ:TLCTaiwan Liposome Company Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:TLC

Seu Histórico Recente

TSXV
PCP.P
Pender Street Capital
UNSW3
$NOWAIETH
NOWAI
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados